IMA Kerala Medical Journal

  • Home
  • AI Submit
  • Current Issue
  • Guidelines
  • Editorial Board
  • Archives
  • Contact

Escitalopram

Drug Profile, Volume 04 Issue 3 – July to September 2011

Authors

Dr. Sebind Kumar, DPM, DNB (Psych) Vellore, Assistant Professor, Department of Psychiatry, Medical College, Thrissur.


Abstract

Escitalopram belongs to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). It acts by serotonin reuptake inhibition by blocking the serotonin transporter (SERT).
SSRIs are used in psychopharmacology and have a long half life- 22-27 hours. It is safe and is one of the most prescribed psychiatric drugs.
Keywords: SSRIs, Serotonin Reuptake Inhibition, Indications.


Full Article

Download Full Article (PDF)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Recent Articles

  • Challenging Cholesterol
  • Problems in the Implementation of Biomedical Waste Management Programme at Government Medical College Hospital, Thiruvananthapuram – A Qualitative Study
  • Do We Achieve target Lipid Levels with Statins in Patients with Coronary Artery Disease?
  • Clinico-Pathology Study of Vitellointestinal Remnants in Children
  • Understanding Depressive Disorders
  • Interstitial Pneumonia in Chikungunya Infection
  • Re-expansion Pulmonary Oedema
  • Mobile Phones and Health Hazards
  • Sitagliptin: The First in a New Class of DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
  • Smoking Cessation: Initial Insights into a New Drug

Kerala Medical Journal All Rights Reserved | Powered by New Clinician